KCTD5 and cancer: In addition, we investigated heterozygous amplifications (CNV = 1) and heterozygous deletions (CNV = -1) of KCTD5 in various cancers and found that heterozygous amplifications occurred frequently in KIRP, BRCA, ACC, and KICH, while heterozygous deletions were more common in UCS, OV, BLCA, and LUSC (Fig. 3B-C).